Item 2.02. Disclosure of Results of Operations and Financial Condition.

On October 29, 2020 we issued the press release attached as Exhibit 99.1. It is incorporated into this report by reference. The press release describes the results of our operations for the quarter ended September 30, 2020.

Item 8.01. Other Events.

On October 29, 2020 we announced that our board of directors declared a quarterly cash dividend of US $0.39 per share. The dividend will have a record date of November 12, 2020, payable on December 17, 2020. The dividend will be paid in U.S. currency to holders of ResMed's common stock trading on the New York Stock Exchange. Holders of Chess Depositary Instruments trading on the Australian Securities Exchange will receive an equivalent amount in Australian currency, based on the exchange rate on the record date, and reflecting the 10:1 ratio between CDIs and NYSE shares. The ex-dividend date will be November 11, 2020 for common stockholders and for CDI holders. ResMed has received a waiver from the ASX's settlement operating rules, which will allow ResMed to defer processing conversions between its common stock and CDI registers from November 11, 2020 through November 12, 2020, inclusive.

Item 9.01. Financial Statements and Exhibits.




(d)  Exhibits



Exhibits:      Description of Document

99.1             Press Release dated October 29, 2020 regarding results of
               operations

104            Cover Page Interactive Data File (embedded within the Inline XBRL
               document)




                                      -2-

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses